Startup Magenta Therapeutics licenses technologies from Harvard, MGH, and Boston Children’s that could transform treatment

Innovations in treating cancer and infection by inhibiting the PD-1 pathway; nanoelectronic tissue scaffolds; soft robotic actuators; generating direct triplet entangled photons, and more

First annual Harvard FUSION symposium assembles leaders at the convergence of science and business

Innovations in chitin composites, deacetylase inhibitors, protein surface remodeling, mass spectrometry, gait analysis, and more